🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a pilot clinical trial investigating the addition of haploidentical...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2014-10-10
Trial ID
NCT02130869
The purpose is to demonstrate that vasoreactivity of patients with septic s...
Status
Completed
Location
Multiple Locations
Start Date
2008-02
Trial ID
NCT02885168
Treatments Being Tested
The aim of this work is to assess the antitumor effect of Pentoxiphylline i...
Status
Unknown
Location
Multiple Locations
Start Date
2023-11-01
Trial ID
NCT06115174
Treatments Being Tested
The purpose of this study is to investigate the coagulation balance in a co...
Status
Completed
Location
Hôpital Necker Enfants malades
Start Date
2014-01-01
Trial ID
NCT03560570
Treatments Being Tested
Approximately 90% of children with malignant brain tumors that have recurre...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2018-03-05
Trial ID
NCT03434262
Treatments Being Tested
Severe haemophilia A and B (SHA, SHB) are X - linked inherited bleeding dis...
Status
Unknown
Location
Royal Free Hospital
Start Date
2017-09-19
Trial ID
NCT03287999
Treatments Being Tested
The main goal of this research study is to determine how nivolumab and nivo...
Status
Completed
Location
UPMC Hillman Cancer Center
Start Date
2020-09-02
Trial ID
NCT04401995
Treatments Being Tested
Activation of the RIG-I innate immune pathway and increased expression of t...
Status
Active Not Recruiting
Location
University of Colorado Hospital
Start Date
2022-06-20
Trial ID
NCT05089370
Treatments Being Tested
The investigators are examining the activation of insulin signaling factors...
Status
Completed
Location
VA Medical Center
Start Date
2000-05
Trial ID
NCT00690755
This is an open-label, phase 1/1b study evaluating the safety, tolerability...
Status
Recruiting
Location
START Midwest
Start Date
2025-12-30
Trial ID
NCT07361562
Treatments Being Tested